According to Optomed's shareholder register of 2 January 2020, the shareholders represented in the shareholders' Nomination Board are Jun Wu's controlled entities (Alnair Investments, Cenova China Healthcare Fund IV and Shanghai Cenova Innovation Venture Fund (Limited Partnership)), Aura Capital Oy and Mandatum Life Insurance Company. These shareholders have appointed the following persons to the Nomination Board: Hai Wu, Jun Wu's controlled entities; Jarmo Malin, Aura Capital Oy; Ville Talasmäki, Mandatum Life Insurance Company; Petri Salonen, Chairman of Optomed's Board of Directors. Petri Salonen, Chairman of Optomed's Board of Directors, will serve as the Nomination Board's expert member.